Papachristodoulou, A., Heidegger, I., Virk, R. K., Di Bernardo, M., Kim, J. Y., Laplaca, C., Picech, F., Schäfer, G., De Castro, G. J., Hibshoosh, H., Loda, M., Klocker, H., Rubin, M. A., Zheng, T., Benson, M. C., McKiernan, J. M., Dutta, A., & Abate-Shen, C. (2024). Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. European Urology, 85(4), 361–372. https://doi.org/10.1016/j.eururo.2023.07.016
Columbia Affiliation:
Subjects:
Metformin
(MeSH)
Prostatic Neoplasms
(MeSH)
Publication Type:
Article
Unique ID:
10.1016/j.eururo.2023.07.016
PMID:
Journal:
Publication Date:
Data Source:
PubMed